findmyKOL
Clinical trialNCT01701349WithdrawnPhase 3Interventional

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

SponsorMateon TherapeuticsEnrollment0Anaplastic Thyroid Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multicenter, double-blind, placebo-controlled, randomized study of fosbretabulin given with chemotherapy (paclitaxel and carboplatin) compared to placebo given with chemotherapy (paclitaxel and carboplatin) in subjects with anaplastic thyroid cancer (ATC). The primary objective of the study is to determine overall survival. A maximum of 300 subjects will be recruited from approximately 75 multinational sites of which approximately 35 will be located in the United States.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Julie A Sosa, MD

    Yale University, New Haven, CT 06520

    Principal Investigator
    clinicaltrials.gov ↗
  • Lisa Licitra, MD

    Instituto Nazionale Per Lo Studio E La Cura Dei Tumori, Milan, Italy

    Principal Investigator
    clinicaltrials.gov ↗
  • Marcia Brose, MD, PhD

    University of Pennsylvania, Philadelphia, PA 19104

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fosbretabulin + paclitaxel + carboplatinPlacebo + paclitaxel + carboplatin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2015
Primary completion
30 Apr 2017
Completion
31 Dec 2017
Last update posted
1 May 2014
Registered enrollment
0
Registry id
NCT01701349
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.